Martín-Lozano G, Gómez-Díaz R, Iglesías-Martín F, Torres-Lagares D, Gutiérrez-Corrales A, Gutiérrez-Pérez JL. Mutations in p53 Gene Exons in a Sample from the South of Spain in Oral Cancer. J Clin Exp Dent. 2021;13(10):e1001-5.

doi:10.4317/jced.58799

___________

References

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309-316. https://doi.org/10.1016/j.oraloncology.2008.06.002 PMid:18804401

2. Vu AN, Farah CS. Efficacy of narrow band imaging for detection and surveillance of potentially malignant and malignant lesions in the oral cavity and oropharynx: a systematic review. Oral Oncol. 2014;50:413-420. https://doi.org/10.1016/j.oraloncology.2014.02.002 PMid:24618128

3. Chu PY, Tsai TL, Tai SK, Chang SY. Effectiveness of narrow band imaging in patients with oral squamous cell carcinoma after treatment. Head Neck. 2012;34:155-161. https://doi.org/10.1002/hed.21704 PMid:21322082

4. McCullough MJ, Prasad G, Farah CS. Oral mucosal malignancy and potentially malignant lesions:an update on the epidemiology, risk factors, diagnosis and management. Aust Dent J. 2010;55:61-65. https://doi.org/10.1111/j.1834-7819.2010.01200.x PMid:20553246

5. Stoicănescu D, Andreescu N, Belengeanu A, Meszaros N, Cornianu M. Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas. Rom J Morphol Embryol. 2013:54;1107-1113. PMid:24399009

6. Gómez I, Seoane J, Varela-Centelles P, Diz P, Takkouche B. Is diagnostic delay related to advanced-stage oral cancer? A meta-analysis. Eur J Oral Sci. 2009:117;541-546. https://doi.org/10.1111/j.1600-0722.2009.00672.x PMid:19758250

7. Muto M, Katada C, Sano Y, Yoshida S. Narrow band imaging: a new diagnostic approach to visualize angiogenesis in superficial neoplasia. Clin Gastroenterol Hepatol. 2005:3;S16-S20. https://doi.org/10.1016/S1542-3565(05)00262-4 PMid:16012987

8. Rosa EA, Lia EN, Macedo SB, de Amorim RFB. In situ carcinoma developed over oral lichen planus: a case report with analysis of BUB3, p16, p53, Ki67 and SOX4 expression. Journal Appl Oral Sci. 2015;23:442-447. https://doi.org/10.1590/1678-775720150058 PMid:26398519 PMCid:PMC4560507

9. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-580. https://doi.org/10.1111/j.1600-0714.2007.00582.x PMid:17944749

10. Ho MW, Field EA, Field JK, Risk JM, Rajlawat BP, Rogers SN, et al. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. Br J Oral Maxillofac Surg. 2013;51:594-599. https://doi.org/10.1016/j.bjoms.2013.03.014 PMid:23601832

11. Er TK, Wang YY, Chen CC, Herreros-Villanueva M, Liu TC, Yuan SSF. Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing. Oral Dis. 2015;21:872-878. https://doi.org/10.1111/odi.12357 PMid:26173098

12. Hall GL, Shaw RJ, Field EA, Rogers SN, Sutton DN, Woolgar JA, et al. Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev. 2008;17:2174-2179. https://doi.org/10.1158/1055-9965.EPI-07-2867 PMid:18708411

13. Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11:9-22. https://doi.org/10.1038/nrc2982 PMid:21160525

14. Tang S, Xu D, Zho B. Analysis of P53 mutation and invasion front grading in oral squamous cell carcinomas. J Huazhong Univ Sci Technolog Med Sci. 2010;30:525-529. https://doi.org/10.1007/s11596-010-0462-0 PMid:20714883

15. Braakhuis BJ, Leemans CR, Brakenhoff RH. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol. 2005;15:113-120. https://doi.org/10.1016/j.semcancer.2004.08.004 PMid:15652456

16. Tabor MP, van Houten VMM, Kummer JA, Vosjan MJ, Vlasblom R, Snow GB, et al. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene. Genes Chromosomes Cancer. 2002;33:168-177. https://doi.org/10.1002/gcc.10019 PMid:11793443

17. Kashiwazaki H, Tonoki H, Tada M, Chiba I, Shindoh M, Totsuka Y, Iggo R, Moriuchi T. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene. 1997;15:2667-2674. https://doi.org/10.1038/sj.onc.1201438 PMid:9400993

18. Garcia Garcia V, Gonzalez Moles MA, Bascones Martines MA. Bases moleculares del cáncer oral. Revisión bibliográfica. Avances en Odontoestomatologia. 2005;21:287-295. https://doi.org/10.4321/S0213-12852005000600002

19. Diniz Freitas M, Garcia Garcia A, Crespo Abelleira A, Martins Carneiro JL, Gándara Rey JM. Aplicaciones de la citología exfoliativa en el diagnóstico del cáncer oral. Med Oral. 2004;9:355-361.

20. Rogha M, Berjis N, Lajevardi SM, Alamdaran M, Hashemi SM. Identification of R249 Mutation in P53 Gene in Tumoral Tissue of Tongue Cancer. Int J Prev Med. 2019;10:129. https://doi.org/10.4103/ijpvm.IJPVM_50_17 PMid:31516670 PMCid:PMC6711340

21. Graveland AP, Bremmer JF, de Maaker M, Brink A,Cobussen P, Zwart M, Braakhuis BJ, Bloemena E, van der Waal I, Leemans CR, Brakenhoff RH. Molecular screening of oral precancer. Oral Oncol. 2013;49:1129-1135. https://doi.org/10.1016/j.oraloncology.2013.09.005 PMid:24120275

22. Warnakulasuriya S, Soussi T, Maher R, Johnson N, Tavassoli M. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol. 2000;192:52-57. https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH669>3.0.CO;2-C PMid:10951400

23. Eversol LR. Dysplasia of the upper aerodigestive tract squamous epithelium. Head and Neck Pathology. 2009;3:63-68. https://doi.org/10.1007/s12105-009-0103-8 PMid:20596993 PMCid:PMC2807542